Search PubMed⌕ Search

Biomedical subjects

Y Katz

Publications and source records attributed to Y Katz.

At least 145 records · Page 8Linked to original sources
PubMed1982

The vomeronasal organ: primary role in mouse chemosensory gender recognition.

Four experiments were conducted to determine the chemosensory modality that supports ultrasonic courtship vocalizations by male mice to females and to chemosignals from females. Both removal of the olfactory bulbs (Experiment 1) and removal of the vomeronasal organ (Experiments 2-4) produced similar deficits in the pattern of ultrasonic vocalizations elicited by conspecifics or their odors. Removal of the vomeronasal organ did not impair the ability to locate food buried under cage shavings. These results are consistent with the notion that the analysis of food related odors is subserved by olfaction and that vocalizations to sex chemosignals are elicited primarily by stimulation of the vomeronasal organ/accessory olfactory bulb. Removal of the vomeronasal organ did not induce seminal vesicle regression or lower plasma immunoreactive testosterone levels (Experiment 2) nor was an attempt to restore vocalizations with exogenous testosterone successful (Experiment 4). Thus the altered vocalization pattern following removal of the vomeronasal organ does not appear to arise as a motivational deficit mediated by androgens. Experiments 2 and 3 demonstrated that, in the absence of the vomeronasal organ, stimulation of other sensory systems can, to some extent, maintain the male's tendency to vocalize more to females or their odors than to males or their odors. However, this responsiveness to females may rely upon additional behavioral cues. Previous experience also plays a considerable role in the response to chemosensory gender cues by males who lack their vomeronasal organs. Removal of the vomeronasal organ prior to adult heterosexual encounters (Experiment 3) virtually eliminated the male's responsiveness to either anesthetized females or their chemosignals. Hence males require adult heterosexual experience with a functioning vomeronasal organ before other chemosensory systems acquire the ability to mediate gender recognition as measured by ultrasonic vocalizations.

Animals↗
PubMed1976

Inhibition of ovarian estradiol-17beta secretion by luteinizing hormone in prepubertal, pregnant mare serum-treated rats.

Serum estradiol-17beta levels, elevated prior to the luteinizing hormone (LH) surge, decline abruptly following the release of endogenous LH or the injection of exogenous LH. To investigate the mechanism of this decline, bovine LH (NIH-LH-B8) was administered to immature rats, in which follicular maturation and estrogen biosynthesis were induced by a non-ovulating dose of pregnant mare serum gonadotropin (PMS). Serum and ovarian estradiol-17beta concentrations fell detectably by 4h, and reached levels around 20% of the controls by 8h after iv injection of 10 mug LH. Concomitant decreases occurred in ovarian androgen concentrations, following an initial rise, and in the in vitro ovarian testosterone aromatizing enzyme activity. The LH-induced inhibition of the aromatase activity was found to be of a non-competitive type. It is proposed that two enzyme systems are inhibited as a result of the LH treatment: the C17,20-lyase and the C19 androgen aromatase, thereby leading to decreased concentrations of estrogens in the ovaries and blood.

Androgens↗
PubMed1975

Calculation of the percentage of a narcotic gas to permit abolition of the high pressure nervous syndrome.

A theoretical method is derived for computation of the interactin of pressure and a weak anesthetic such as nitrogen or other narcotic gases in a two-dimensional material so as to prevent signs and symptoms of the high pressure nervous syndrome. A ratio of one part nitogen to 9 parts helium (pressure) is derived, which is in excellent agreement with previous human experiments in men at 31 ATA, with PO2 = 0.5 ATA.

Diving↗
PubMedDate not supplied

Midazolam in treatment of epileptic seizures.

Midazolam (Versed), the first water-soluble benzodiazepine, has had widespread acceptance as a parenteral anxiolitic agent. Its antiepileptic properties were studied in adult patients with good results. Midazolam was administered intramuscularly to 48 children, ages 4 months to 14 years, with 69 epileptic episodes of various types. In all but 5 epileptic episodes, seizures stopped 1-10 min after injection. These results suggest that midazolam administered intramuscularly may be useful in a variety of epileptic seizures during childhood, specifically when attempts to introduce an intravenous line in convulsing children are unsuccessful.

Adolescent↗